Chlamydial female pelvic inflammatory disease
ICD-10 A56.4 is a billable code used to indicate a diagnosis of chlamydial female pelvic inflammatory disease.
Chlamydial female pelvic inflammatory disease (PID) is an infection of the female reproductive organs caused by the bacterium Chlamydia trachomatis. This condition often arises from untreated chlamydial infections, which are common sexually transmitted infections (STIs). PID can lead to serious complications, including chronic pelvic pain, infertility, and ectopic pregnancy. Symptoms may include lower abdominal pain, fever, unusual vaginal discharge, and pain during intercourse. Diagnosis typically involves a combination of clinical evaluation, laboratory testing for chlamydia, and imaging studies if necessary. Treatment usually consists of antibiotics, and it is crucial to treat sexual partners to prevent reinfection. Regular screening for STIs is recommended for sexually active women under 25 and those with risk factors. Effective management of chlamydial PID requires a comprehensive approach, including patient education on safe sex practices and the importance of follow-up care.
Detailed patient history, physical examination findings, and treatment plans.
Diagnosis and management of PID, routine STI screenings, and treatment of chlamydial infections.
Ensure documentation reflects the severity of symptoms and any complications.
Comprehensive records of laboratory results, treatment regimens, and follow-up care.
Management of complex cases with multiple STIs and chronic infections.
Document any co-infections and their impact on treatment outcomes.
Used for testing in patients suspected of having chlamydial PID.
Document the reason for testing and results.
Gynecologists should ensure proper coding for STI screenings.
Common symptoms include lower abdominal pain, fever, unusual vaginal discharge, and pain during intercourse. Some women may be asymptomatic.
Diagnosis is typically made through a combination of clinical evaluation, laboratory testing for chlamydia, and imaging studies if necessary.
Treatment usually involves a course of antibiotics, and it is essential to treat sexual partners to prevent reinfection.
Contact tracing helps to identify and treat sexual partners, reducing the risk of reinfection and further transmission of the infection.
